Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL23R | Q5VWK5 | 2/20 | 0.67 |
| ▸ | MC4R | P32245 | 2/20 | 0.64 |
| ▸ | MC5R | P33032 | 2/20 | 0.64 |
| ▸ | MC3R | P41968 | 2/20 | 0.64 |
| ▸ | MC1R | Q01726 | 2/20 | 0.64 |
| ▸ | CXCR4 | P61073 | 6/20 | 0.61 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.60 |
| ▸ | OPRK1 | P41145 | 6/20 | 0.60 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.59 |
| ▸ | CTSL | P07711 | 3/20 | 0.59 |
| ▸ | CTSS | P25774 | 3/20 | 0.59 |
| ▸ | CTSK | P43235 | 3/20 | 0.59 |
| ▸ | CTSH | P09668 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30518034 | 0.97 | IL23R (0.64) | IL23RMC4RMC5RMC3RMC1R | |
| SCHEMBL31105433 | 0.94 | IL23R (0.69) | IL23RMC4RMC5RMC3RMC1R | |
| SCHEMBL13144891 | 0.90 | KISS1R (0.58) | IL23RMC4RMC5RMC3RMC1R | |
| SCHEMBL31187042 | 0.88 | CXCR4 (0.63) | IL23RMC4RMC5RMC3RMC1R | |
| SCHEMBL16455572 | 0.88 | MC4R (0.65) | IL23RMC4RMC5RMC3RMC1R | |
| SCHEMBL31105513 | 0.87 | IL23R (0.66) | IL23RMC4RMC5RMC3RMC1R | |
| Venorphin SCHEMBL30516272 | 0.87 | OPRM1 (0.67) | IL23RCXCR4OPRM1OPRK1 | |
| SCHEMBL29853539 | 0.87 | C5AR1 (0.62) | IL23RMC4RMC5RMC3RMC1R | |
| SCHEMBL29164282 | 0.86 | MC4R (0.62) | IL23RMC4RMC5RMC3RMC1R | |
| SCHEMBL29164274 | 0.86 | MC4R (0.62) | IL23RMC4RMC5RMC3RMC1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260078144-A1 | ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF | WINKEY TECH USA INC (US) | 2026-03-19 | — | — | US | claimed |
| WO-2024217503-A1 | ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF | 深圳市维琪科技股份有限公司 | 2024-10-24 | — | — | WO | claimed |
| US-20260078144-A1 | ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF | WINKEY TECH USA INC (US) | 2026-03-19 | — | — | US | disclosed |
| WO-2024217503-A1 | ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF | 深圳市维琪科技股份有限公司 | 2024-10-24 | — | — | WO | disclosed |
| CN-117343140-B | Active peptide, composition and use thereof | 深圳市维琪科技股份有限公司 | 2024-09-20 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078144-A1 | ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF | ARGLU1, ARG1, POT1 | IL23R 4196/4885MC4R 72/4885MC5R 114/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.